TopFunds

Novo Nordisk A/S

NYSE: NVO

Stock price

43.24 USD

(-14.73%) 5 years

medicineDrug Manufacturers - GeneralInvestable Universe

Insider Transactions

5Y price score: (20)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -14.73%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
No insider transactions available.

35.1

52-week range

64.1

43.24

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

3.9 %

Dividend Yield TTM

4.4 %

Market cap $

$ 192,012

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

10.7

Price / Book TTM

5.6

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

6.1

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

(27.3) %

(3.4) %

126.2 %

Free cash flow per share growth

73.4 %

2.1 %

5.4 %

Earnings per share growth

(20.5) %

155.6 %

240.7 %

Dividends

Previous dividend:0.5792 per share, Paid, Ex-div date Aug 17, 2026

Analyst ratings

Price Target Low

40

Price Target High

47

Price Target Median

47

Buy

23

Hold

13

Sell

3

Financials

all figures in DKK Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
6.8
7.5
7.7
8
8.2
9
10.4
12.2
18.6
22.6
23
13%
26.3
29.7
33.4
37.7
42.5
44.4
02FCF per share
6.2
7.9
6.6
6.6
7.5
6.4
10.3
14.1
15.6
15.6
6.5
0.5%
4.9
0.4
(6.5)
(16.4)
(30.5)
(54.6)
03Dividends per share
Help
Adjusted for splitsLearn more
0.4
0.7
0.6
0.6
0.6
0.7
0.7
0.8
1
1.4
1.7
16.8%
-
-
-
-
-
-
04Dividends payout, %
37%
62.8%
49.4%
49.3%
49.8%
47.8%
45.1%
45.6%
38%
43.7%
50.5%
3.2%
-
-
-
-
-
-
05Revenue
$ 107,927
$ 111,780
$ 111,696
$ 111,831
$ 122,021
$ 126,946
$ 140,800
$ 176,954
$ 232,261
$ 290,403
$ 309,064
11.1%
$ 343,353
$ 381,445
$ 423,764
$ 470,778
$ 523,007
$ 538,697
06ㅤ% Change
-
3.6%
(0.1)%
0.1%
9.1%
4%
10.9%
25.7%
31.3%
25%
6.4%
11.1%
11.1%
11.1%
11.1%
11.1%
11.1%
11.1%
07Net Income
34,860
37,925
38,130
38,628
38,951
42,138
47,757
55,525
83,683
100,988
102,434
11.4%
115,262
128,050
142,256
158,039
175,572
180,839
08ㅤ% Margin
32.3%
33.9%
34.1%
34.5%
31.9%
33.2%
33.9%
31.4%
36%
34.8%
33.1%
33.6% A
33.6%
33.6%
33.6%
33.6%
33.6%
33.6%
09CFO
38,287
48,314
41,168
44,616
46,782
51,951
55,000
78,887
108,908
120,968
119,102
12%
139,039
154,464
171,601
190,639
211,789
218,142
10ㅤ% Of revenue
35.5%
43.2%
36.9%
39.9%
38.3%
40.9%
39.1%
44.6%
46.9%
41.7%
38.5%
40.5% A
40.5%
40.5%
40.5%
40.5%
40.5%
40.5%
11CAPEX
(6,406)
(8,267)
(8,648)
(12,410)
(11,231)
(22,081)
(7,385)
(14,753)
(38,896)
(51,309)
(90,113)
30.3%
(117,384)
(152,907)
(199,181)
(259,458)
(337,977)
(440,259)
12ㅤ% Change
-
29.1%
4.6%
43.5%
(9.5)%
96.6%
(66.6)%
99.8%
163.7%
31.9%
75.6%
30.3% A
30.3%
30.3%
30.3%
30.3%
30.3%
30.3%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
31,881
40,047
32,520
32,206
35,551
29,870
47,615
64,134
70,012
69,659
28,989
(1)%
21,655
1,557
(27,580)
(68,820)
(126,189)
(222,116)
14Total assets
91,799
97,539
102,355
110,769
18,869
23,822
194,508
241,257
314,486
465,795
542,902
19.5%
648,500
774,637
925,308
1,105,286
1,320,271
1,577,072
15ㅤ% Change
-
6.3%
4.9%
8.2%
(83)%
26.3%
716.5%
24%
30.4%
48.1%
16.6%
19.5%
19.5%
19.5%
19.5%
19.5%
19.5%
19.5%
16Total liabilities
44,830
52,270
52,540
58,930
10,218
13,413
123,762
157,771
207,925
322,309
348,855
22.8%
416,709
497,762
594,580
710,229
848,373
1,013,386
17ㅤ% Of assets
48.8%
53.6%
51.3%
53.2%
54.2%
56.3%
63.6%
65.4%
66.1%
69.2%
64.3%
64.3% A
64.3%
64.3%
64.3%
64.3%
64.3%
64.3%
18Shareholders Equity
46,969
45,269
49,815
51,839
8,652
10,409
70,746
83,486
106,561
143,486
194,047
15.2%
231,790
276,875
330,729
395,058
471,899
563,686
19Net Debt
(15,850)
(18,461)
(17,158)
(15,123)
(1,651)
(394.7)
15,925
13,131
12,614
87,132
104,494
-
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
5,156,805
5,070,187
4,956,186
4,848,834
4,757,316
4,680,000
4,606,200
4,544,600
4,494,800
4,463,000
4,447,851
(1.5)%
4,382,553
4,318,214
4,254,819
4,192,355
4,130,808
4,070,164
21ㅤ% Change
-
(1.7)%
(2.3)%
(2.2)%
(1.9)%
(1.6)%
(1.6)%
(1.3)%
(1.1)%
(0.7)%
(0.3)%
(1.5)%
(1.5)%
(1.5)%
(1.5)%
(1.5)%
(1.5)%
(1.5)%
22ROA
38%
38.9%
37.3%
34.9%
206.4%
176.9%
24.6%
23%
26.6%
21.7%
18.9%
-
17.8%
16.5%
15.4%
14.3%
13.3%
11.5%
23ROE
74.2%
83.8%
76.5%
74.5%
450.2%
404.8%
67.5%
66.5%
78.5%
70.4%
52.8%
-
49.7%
46.3%
43%
40%
37.2%
32.1%
24Interest coverage
738
745.1
544.1
555.9
104.8
100.2
142.7
133.8
138.8
66.5
18.8
-
-
-
-
-
-
-
25Dividend Yield
1.3%
3.7%
2.3%
2.6%
2.1%
2%
1.3%
1.2%
1%
1.6%
3.6%
-
-
-
-
-
-
-
26P/E Ratio
29.5
17
21.7
19.1
23.5
23.6
35.3
38.3
37.4
27.5
14.1
-
-
-
-
-
-
-
27Stock price range
21-30
16-29
16-27
21-29
23-29
25-37
34-59
47-68
66-105
85-147
45-91
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
1,028,062
644,377
825,956
736,285
917,999
995,735
1,688,379
2,124,851
3,129,443
2,780,124
1,445,086
3.5%
(2,199,840)
(2,409,375)
(2,639,863)
(2,893,400)
(3,172,290)
-
29FCF Yield
3.1%
6.2%
3.9%
4.4%
3.9%
3%
2.8%
3%
2.2%
2.5%
2%
(4.3)%
(1)%
(0.1)%
1%
2.4%
4%
-
30Average stock price
25.5
22.4
21.7
24.9
26.2
30.8
46
57.1
85.8
116
68
10.3%
(502)
(558)
(620.4)
(690.2)
(768)
-
31 CEO
LJ
Mr. Lars Fruergaard Jorgensen
MD
Maziar Mike Doustdar